Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)

SHA:688658 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,455	1,333	1,483	1,661	2,437	2,536
Trading Asset Securities	100.03	160.26	-	-	-	-
Cash & Short-Term Investments	1,555	1,493	1,483	1,661	2,437	2,536
Cash Growth	-10.24%	0.72%	-10.76%	-31.84%	-3.88%	542.35%
Accounts Receivable	705.01	805.43	1,094	1,366	927.02	669.43
Other Receivables	27.8	10.67	1.58	0.22	2.28	15.93
Receivables	732.81	816.1	1,095	1,366	929.3	685.36
Inventory	645.47	757.34	727.69	738.34	632.31	626.6
Other Current Assets	104.51	91.33	119.24	135.64	66.91	44.48
Total Current Assets	3,038	3,158	3,425	3,901	4,066	3,892
Property, Plant & Equipment	2,032	1,999	1,960	1,671	1,302	1,314
Long-Term Investments	33.1	33.1	15.75	-	-	-
Other Intangible Assets	168.87	175.01	174.32	174.68	181.14	134.04
Long-Term Deferred Tax Assets	28.08	30.32	20.39	17.82	12.35	8.95
Long-Term Deferred Charges	295.52	293.89	270.65	194.9	97.87	87.25
Other Long-Term Assets	15.97	48.57	45.5	49.34	67.81	20.61
Total Assets	5,611	5,738	5,911	6,009	5,727	5,457
Accounts Payable	550.53	559.34	592.05	711.18	771.73	747.4
Accrued Expenses	50.5	556.47	891.65	725.52	655.5	546.92
Short-Term Debt	103.13	112.97	351.77	228.35	9.01	160.24
Current Portion of Long-Term Debt	100.09	51.67	16.84	-	-	-
Current Portion of Leases	-	9.23	10.34	9.68	4.77	41.37
Current Income Taxes Payable	29.31	0.51	16.41	1.02	57.03	26.71
Current Unearned Revenue	56.5	44.54	29.68	57.09	40.03	73.86
Other Current Liabilities	511.68	170.77	227.89	166.51	144.13	182.67
Total Current Liabilities	1,402	1,506	2,137	1,899	1,682	1,779
Long-Term Debt	538.09	516.97	54.57	-	-	-
Long-Term Leases	12.05	14.46	29.38	39.72	23.77	-
Long-Term Unearned Revenue	123.98	116.21	93.05	72.32	93.7	91.93
Total Liabilities	2,076	2,153	2,314	2,011	1,800	1,871
Common Stock	450	450	450	450	450	450
Additional Paid-In Capital	2,645	2,645	2,645	2,681	2,645	2,645
Retained Earnings	533.2	582.47	547.65	857.86	828.56	485.75
Treasury Stock	-100.02	-100.02	-54.99	-	-	-
Total Common Equity	3,528	3,578	3,588	3,989	3,924	3,581
Minority Interest	7.1	7.33	9.8	8.09	3.38	4.97
Shareholders' Equity	3,535	3,585	3,598	3,997	3,927	3,586
Total Liabilities & Equity	5,611	5,738	5,911	6,009	5,727	5,457
Total Debt	753.36	705.31	462.91	277.75	37.55	201.61
Net Cash (Debt)	801.65	787.86	1,020	1,384	2,400	2,334
Net Cash Growth	-20.41%	-22.73%	-26.31%	-42.34%	2.81%	-
Net Cash Per Share	1.83	1.78	2.26	3.05	5.32	6.49
Filing Date Shares Outstanding	444.48	444.48	447.18	450	450	450
Total Common Shares Outstanding	444.48	444.48	447.18	450	450	450
Working Capital	1,636	1,652	1,288	2,002	2,384	2,113
Book Value Per Share	7.94	8.05	8.02	8.87	8.72	7.96
Tangible Book Value	3,359	3,403	3,414	3,815	3,743	3,447
Tangible Book Value Per Share	7.56	7.66	7.63	8.48	8.32	7.66
Buildings	-	1,417	1,314	1,127	1,135	1,102
Machinery	-	1,203	1,166	958.27	871.85	799.61
Construction In Progress	-	539.86	470.99	458.45	74.95	107.77

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.